Genetic Polymorphisms of Toll-like receptors 2 and 9 as Susceptibility Factors for the Development of Ankylosing Spondylitis and Psoriatic Arthritis

Table 3

Clinical characteristics of patient groups.

	SpA	AS	PsA
Female/male ( as %)	79/70 (53.0/47.0)	51/44 (52.7/47.3)	28/26 (51.8/48.1)
Family history SpA ( as %)	39 (58.1)	9 (13.4)	30 (44.7)
( as %)	104 (69.8)	69 (73.4)	35 (65.5)
Disease duration-years ()
Treatment time-years ()
HLA-B27 ( as %)
Present	83 (55.7)	53 (55.8)	30 (55.5)
Absent	66 (44.3)	42 (44.2)	24 (44.5)

SpA: patients with spondyloarthritis; AS: ankylosing spondylitis; PsA: psoriatic arthritis; BASDAI: Bath Ankylosing Spondylitis Disease Activity Index.